|
PSCI-21-133 |
A mixed-methods implementation evaluation of a pilot study to increase self-sampling for cancer screening: Interviews with previous study participants |
|
PSCI-21-158 |
Radiopaque Hydrogel Rectal Spacer for Prostate Cancer Radiation Image Guidance |
|
PSCI-21-160 |
A Single-Arm, Open-Label Pharmacokinetic, Safety, and Efficacy Study of ASTX727 in Combination with Venetoclax in Adult Patients with Acute Myeloid Leukemia |
|
PSCI-21-161 |
Adolescent and young adult professional and Olympian athlete cancer survivors |
|
PSCI-21-163 |
A Safety, Pharmacokinetic and Efficacy Study of a ;-Secretase Inhibitor, Nirogacestat (PF-03084014; IND# 146375), in Children and Adolescents with Progressive, Surgically Unresectable Desmoid Tumors |
|
PSCI-21-173 |
Angelica Herbal Supplement AGN-CognI.Q Acute Dose Safety and Pharmacokinetics (PK) Dose-Response in Prostate Cancer Patients (PK Dose Trial) |
|
PSCI-21-185 |
Increasing cancer screening among female patients at PSH St. Joseph s residency clinic: Offering a self-sampling option in clinic |
|
PSCI-21-188 |
An open-label phase II study to investigate the efficacy, safety, and pharmacokinetics of tirabrutinib in patients with Primary Central Nervous System Lymphoma (PCNSL) |
|
PSCI-21-190 |
An Open-Label, Randomized, Controlled Multi-Center Study of The Efficacy of Daromun (L19IL2 + L19TNF) Neoadjuvant Intratumoral Treatment Followed by Surgery and Adjuvant Therapy Versus Surgery and Adjuvant Therapy in Clinical Stage IIIB/C Melanoma Patients (PSCI 21-190) (PH-L19IL2TNF-01/18) |
|
PSCI-21-200 |
A Phase 3 Randomized Study of Selumetinib (IND # 77782) versus Carboplatin/Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 (NF1) Associated Low-Grade Glioma (LGG) |
